Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Nir Hacohen, Keren Yizhak et al.|Cell|2018Cited by 2k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabineLeore T. Geller, Ravid Straussman, Michal Barzily-Rokni et al.|Science|2017Cited by 1.8k
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionRavid Straussman, Todd R. Golub, Teppei Morikawa et al.|Nature|2012Cited by 1.7k
BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic MelanomaDennie T. Frederick, Jennifer A. Wargo, Adriano Piris et al.|Clinical Cancer Research|2013Cited by 938
MAP Kinase Pathway Alterations in <i>BRAF</i> -Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK InhibitionNikhil Wagle, Levi A. Garraway, Eliezer M. Van Allen et al.|Cancer Discovery|2013Cited by 473